Plant HIS1 mutant protein as well as mutant gene and application thereof
By performing amino acid mutations at specific sites on HIS1 protein, it improves its catalytic activity and resistance, and solves the problem of rice being sensitive to β-triketone herbicides, and achieves efficient resistance to HPPD inhibitor herbicides, which promotes the Development of herbicide resistant crops.
Patent Information
- Application Number
- CN202411378574.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-30
- Publication Date
- 2024-11-15
AI Technical Summary
Existing rice is sensitive to β-triketone herbicides, which leads to the safety risks of its promotion in the field. The wild-type HIS1 protein has low catalytic activity on these herbicides, making it difficult to meet actual needs.
By mutation of rice wild-type HIS1 protein or other plant HIS1 homologous proteins at specific amino acid sites, the α-ketoglutarate-dependent oxygenase activity and resistance to nitrosulone and cyclosulone are improved. Thus, HIS1 mutant protein with higher catalytic activity was developed for plants that were anti-HPPD inhibitor-type herbicides.
The resistance of rice or wheat to HPPD inhibitor herbicides is achieved, and the tolerance of plants to these herbicides is improved, providing new herbicide-resistant crops and corresponding acquisition methods.
Smart Images

Figure CN118956792A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of plant protein and plant resistance to herbicides, and specifically relates to a plant HIS1 mutant protein and its mutant gene and application. Specifically, the present invention relates to an α-ketoglutarate-dependent oxygenase (HIS1) mutant gene and a mutant HIS1 protein encoded by the mutant protein, which can give plants, especially rice, the property of resistance to para-hydroxyphenylpyruvate dioxygenase inhibitor herbicides. The present invention discloses the nucleotide sequence and amino acid sequence of the mutant protein, and their application in the field of plant resistance to herbicides. Background Art
[0002] Weeds in paddy fields are one of the main factors affecting rice yield and grain quality. They compete with rice for nutrients, water, sunlight and space, resulting in reduced rice yield and even complete crop failure in some cases. Chemical weed control is currently the most commonly used weed control measure, which can greatly improve labor productivity, reduce labor production intensity, and thus improve economic benefits. Hydroxyphenylpyruvate dioxygenase (HPPD) is a key enzyme in the tyrosine metabolic pathway in organisms, participates in a variety of biological processes, and has become an important target for herbicide development. HPPD inhibitor herbicides, represented by β-triketone herbicides, have the characteristics of high efficiency, broad spectrum, good storage stability in aqueous solution, and good physical compatibility with other herbicides, and have become an important tool for dealing with weed damage in the future. However, since some indica rice is sensitive to β-triketone herbicides, there are safety risks in the promotion and use of this type of herbicide in rice fields. Based on this, the development of β-triketone herbicide-resistant rice has become an important research direction in current rice breeding. In 2019, Maeda H et al. first identified the HIS1 gene from japonica rice. This gene encodes an α-ketoglutarate-dependent oxygenase that can catalyze the hydroxylation reaction of a variety of β-triketone herbicides. The binding ability of the reaction product with HPPD will be significantly weakened, thereby giving japonica rice tolerance to HPPD herbicides. It has great potential in the development of β-triketone herbicide-resistant rice. However, the current wild-type HIS1 protein has low catalytic activity against β-triketone herbicides, which is difficult to meet actual needs.
[0003] Therefore, it is of great theoretical significance and economic value to obtain HIS1 protein with significantly enhanced metabolic activity against HPPD inhibitor herbicides through modification, and to develop new herbicide-resistant crops, such as rice or wheat, resistant to HPPD inhibitor herbicides based on this. Summary of the invention
[0004] Purpose of the invention: The technical problem to be solved by the present invention is to provide a HIS1 mutant protein and apply it to the creation of herbicide-resistant rice or wheat.
[0005] The technical problem to be solved by the present invention is to provide a HIS1 mutant gene.
[0006] The technical problem to be solved by the present invention is to provide an expression cassette, a recombinant vector or a recombinant bacterium.
[0007] The technical problem to be solved by the present invention is to provide the application of the HIS1 mutant protein, the HIS1 mutant gene, the expression cassette, the recombinant vector or the recombinant bacteria in cultivating plants resistant to HPPD inhibitor herbicides.
[0008] The technical problem to be solved by the present invention is to provide a method for obtaining plants resistant to HPPD inhibitor herbicides.
[0009] The final technical problem to be solved by the present invention is to provide a method for identifying plants that are resistant to HPPD inhibitor herbicides.
[0010] Technical solution: In order to solve the above technical problems, the present invention provides a HIS1 mutant protein, wherein the HIS1 mutant protein is selected from at least one of the following proteins (a), (b), (c) or (d):
[0011] (a) the amino acid 229 of the wild-type rice HIS1 protein or the HIS1 homologous protein of other plants is mutated at the corresponding site so that the protein has α-ketoglutarate-dependent oxygenase activity and / or has mesotrione resistance and / or has tembotrione resistance; the amino acid sequence of the wild-type rice HIS1 protein is shown in SEQ ID No. 1;
[0012] (b) the amino acid 336 of the wild-type rice HIS1 protein or the HIS1 homologous protein of other plants is mutated at the corresponding position so that the protein has α-ketoglutarate-dependent oxygenase activity and / or mesotrione resistance and / or tembotrione resistance; the amino acid sequence of the wild-type rice HIS1 protein is shown in SEQ ID No. 1;
[0013] (c) a protein derived from (a) in which the amino acid sequence in (a) or (b) is substituted, deleted or added with one or more amino acids and has α-ketoglutarate-dependent oxygenase activity and / or mesotrione resistance and / or tembotrione resistance;
[0014] (d) a protein having at least 85% amino acid sequence identity with any one of the HIS1 mutant proteins in (a), (b) or (c) above, and having higher α-ketoglutarate-dependent oxygenase activity and / or mesotrione resistance and / or tembotrione resistance than the plant wild-type HIS1 protein.
[0015] Wherein, the HIS1 mutant protein is selected from at least one of the following proteins (1), (2) or (3):
[0016] (1) A protein derived from the amino acid 229 of the amino acid sequence shown in SEQ ID NO.1 or a HIS1 homologous protein of other plants after the corresponding site is mutated from glycine to alanine or methionine;
[0017] (2) a protein derived from the amino acid 336 in the amino acid sequence of SEQ ID NO.1 or a HIS1 homologous protein of other plants mutated from phenylalanine to alanine, aspartic acid, asparagine, glutamic acid, glutamine, valine, arginine, methionine, serine, glycine, threonine or cysteine at the corresponding position;
[0018] (3) A protein derived from a mutation simultaneously occurring at amino acid position 229 and amino acid position 336 in the amino acid sequence of SEQ ID NO. 1 or at the corresponding positions of a HIS1 homologous protein of other plants, specifically selected from the following mutant forms: G229A / F336D, G229A / F336N, G229A / F336E, G229A / F336Q, G229A / F336V, G229A / F336R, G229A / F336M, G229A / F336S, G229A / F336V 6G, G229A / F336T, G229A / F336C, G229A / F336A, G229M / F336D, G229M / F336N, G229M / F336E, G229M / F336Q, G229 M / F336V, G229M / F336R, G229M / F336M, G229M / F336S, G229M / F336G, G229M / F336T, G229M / F336C or G229M / F336A.
[0019] Wherein, the other plants include wheat, corn, soybean, cotton or rapeseed; when the plant is wheat, the homologous site of the 229th amino acid site of the wild-type rice HIS1 protein is located at the 230th amino acid site of the wild-type wheat HIS1 protein; the homologous site of the 336th amino acid site of the wild-type rice HIS1 protein is located at the 337th amino acid site of the wild-type wheat HIS1 protein.
[0020] Wherein, when the plant is wheat, the wheat HIS1 mutant protein is selected from at least one of the following proteins (i) or (ii) or (iii):
[0021] (i) a protein derived from the amino acid sequence of SEQ ID NO. 5 wherein the 230th amino acid is mutated from glycine to alanine or methionine;
[0022] (ii) a protein derived from the amino acid sequence of SEQ ID NO. 5 wherein the amino acid at position 337 is mutated from phenylalanine to alanine, aspartic acid, asparagine, glutamic acid, glutamine, valine, arginine, methionine, serine, glycine, threonine or cysteine;
[0023] (iii) a protein derived from a simultaneous mutation of amino acid 230 and amino acid 337 in the amino acid sequence of SEQ ID NO.5, specifically selected from the following mutant forms: G230A / F337D, G230A / F337N, G230A / F337E, G230A / F337Q, G230A / F337V, G230A / F337R, G230A / F337M, G230A / F337S, G230A / F337G, G230A / F337V 37T, G230A / F337C, G230A / F337A, G230M / F337D, G230M / F337N, G230M / F336E, G230M / F337Q, G230M / F337 V, G230M / F337R, G230M / F337M, G230M / F337S, G230M / F337G, G230M / F337T, G230M / F337C or G230M / F337A.
[0024] The present invention also includes a HIS1 mutant gene, which encodes the HIS1 mutant protein.
[0025] Wherein, the mutant gene includes any of the following gene sequences:
[0026] (1) The mutant gene has mutated nucleotides 685 to 687 to gca, gct, gcc, gcg or atg relative to the wild-type rice HIS1 gene, and the nucleotide sequence of the wild-type rice HIS1 gene is shown in SEQ ID NO.2;
[0027] (2) The mutant gene has mutated to att, aac, gaa, gag, gat, gac, caa, cag, gtt, gtc, gta, gtg, cgt, cgc, cga, cgg, aga, agg, atg, tct, tcc, tca, tcg, agt, agc, ggt, ggc, gga, ggg, act, acc, aca, acg, tgt, tgc, gca, gct, gcc or gcg at nucleotide positions 1006 to 1008 of the wild-type rice HIS1 gene, and the nucleotide sequence of the wild-type rice HIS1 gene is shown in SEQ ID NO.2;
[0028] (3) The mutant gene has nucleotides 688 to 690 mutated to gca, gct, gcc, gcg or atg relative to the wild-type wheat HIS1 gene, and the nucleotide sequence of the wild-type wheat HIS1 gene is shown in SEQ ID NO.4;
[0029] (4) The mutant gene has mutated to att, aac, gaa, gag, gat, gac, caa, cag, gtt, gtc, gta, gtg, cgt, cgc, cga, cgg, aga, agg, atg, tct, tcc, tca, tcg, agt, agc, ggt, ggc, gga, ggg, act, acc, aca, acg, tgt, tgc, gca, gct, gcc or gcg at nucleotide positions 1009 to 1011 of the wild-type wheat HIS1 gene, and the nucleotide sequence of the wild-type wheat HIS1 gene is shown in SEQ ID NO.4.
[0030] The present invention also includes an expression cassette, a recombinant vector or a recombinant bacterium, which contains the HIS1 mutant gene.
[0031] The present invention also includes the use of the HIS1 mutant protein, the HIS1 mutant gene, the expression cassette, the recombinant vector or the recombinant bacteria in cultivating plants resistant to HPPD inhibitor herbicides. Preferably, the HPPD inhibitor herbicides include one or both of mesotrione or cyproconazole.
[0032] The application includes obtaining plants resistant to HPPD inhibitor herbicides by gene editing, transgenic, mutagenesis, hybridization, backcrossing or asexual reproduction methods.
[0033] Wherein, the HPPD herbicide-resistant plant comprises the HIS1 mutant gene and / or expresses the HIS1 mutant protein.
[0034] The present invention also includes a method for obtaining plants resistant to HPPD inhibitor herbicides, comprising the steps of:
[0035] (1) making the plant contain the mutant gene; or
[0036] (2) causing the plant to express the mutant protein.
[0037] The present invention also includes a method for identifying plants resistant to HPPD inhibitor herbicides, comprising the steps of:
[0038] (1) testing whether the plant contains the mutant gene; or
[0039] (2) Testing whether the plant expresses the protein.
[0040] Beneficial effects: Compared with the prior art, the present invention has the following advantages: The present invention provides a mutant protein that enables plants to have resistance to HPPD inhibitor herbicides, and compared with the wild type, the mutant protein has amino acid mutations at positions 229 and 336. In addition, the present invention also provides corresponding methods and uses for obtaining plants with resistance to HPPD inhibitor herbicides, and methods for identifying the herbicide plants or herbicide-resistant plants of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1 , agarose gel electrophoresis results of PCR amplification of pET-28a plasmid and HIS1 gene.
[0042] Figure 2 , relative enzyme activity of HIS1 single point mutants towards mesotrione.
[0043] Figure 3 , the relative enzyme activity of HIS1 single point mutants towards tembotrione.
[0044] Figure 4 , relative enzyme activity of HIS1 double-point mutants towards mesotrione.
[0045] Figure 5 , the relative enzyme activity of HIS1 double point mutants towards tembotrione.
[0046] Figure 6 , showing the sensitivity results of G229A / F336N mutant T1 generation positive rice plants and HIS1 wild-type T1 generation positive rice plants to HPPD inhibitor herbicides mesotrione and cypermethrin.
[0047] Figure 7 , showing the sensitivity results of G229A / F336N mutant T1 generation positive wheat plants and HIS1 wild-type T1 generation positive wheat plants to the HPPD inhibitor herbicides mesotrione and cypermethrin. DETAILED DESCRIPTION
[0048] The embodiments of the present invention will be described in detail below in conjunction with the examples, but those skilled in the art will appreciate that the following examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. If no specific conditions are specified in the examples, they are carried out according to normal conditions or the conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be obtained commercially.
[0049] Example 1: Cloning of Rice HIS1 Gene
[0050] Primers were designed and synthesized (GenScript, China) based on the coding region sequence of the rice (Oryza sativa Japonica) HIS1 gene (https: / / www.ricedata.cn / , gene ID: LOC_Os02g0280700) and the sequence of the pET-28a vector: 28a-HIS1-F: GAAGGAGATATACATatggctgacgagtcatggagg and 28a-HIS1-R: GTGGTGGTGCTCGAGgatcctcagggagtcgatgtacctc. This pair of primers was used to amplify the rice HIS1 gene using the cDNA of the rice variety Nipponbare as a template according to the standard system in the instructions of the Phanta Max High-Fidelity DNA Polymerase Kit (P505-d1, Novozymes, China). The specific results are shown in the table. Figure 1 . PCR amplification conditions are shown in Table 1:
[0051] Table 1 PCR amplification conditions of rice HIS1 gene
[0052]
[0053] Primer VF was designed and synthesized using the sequence of pET-28a vector:
[0054] CTCGAGCACCACCACCACCAC and VR:
[0055] ATGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAGGGG. Using this pair of primers, the pET-28a plasmid was used as a template to amplify the vector gene according to the standard system in the instruction manual of the Phanta Max High-Fidelity DNA Polymerase Kit (P505-d1, Novozymes, China). The specific results are shown in Figure 1 . PCR amplification conditions are shown in Table 2:
[0056] Table 2 PCR amplification conditions of pET-28a plasmid vector
[0057]
[0058] The PCR amplification product of the vector was digested with restriction endonuclease Dpn I (TaKaRa, Japan) to remove the methylated pET-28a plasmid template. The reaction system and conditions were as follows: vector amplification product, 20 μL; 10×T buffer, 4 μL; Dpn I (10 U / μL), 1 μL; ddH2O, 15 μL; 37°C, 30 min.
[0059] According to the instructions of the DNA purification kit (Axygen, USA), the amplified HIS1 gene fragment and pET-28a vector fragment were recovered to obtain the HIS1 gene fragment containing 15 bp homology arms and the linearized vector fragment. The two purified fragments were connected together using C112 ligase (Cat. No. C112-01, Novozyme, China). The reaction system and reaction conditions were as follows: 5× buffer, 2 μL; HIS1 fragment, 1 μL; pET-28a vector fragment, 1 μL; C112 ligase, 1 μL; ddH2O, 5 μL; 37°C, 30 min. All the ligation products were transferred into 100 μL of slowly thawed DH5α competent cells (Qingke, China), gently pipetted to mix, placed on ice for 30 min, in a 42°C water bath for 45 s, placed on ice for 2 min, added with 500 μL of liquid LB medium without antibiotics, and cultured at 37°C 220 rpm for 1 h, spread on a solid LB medium plate containing 50 μg / mL kanamycin, placed in a 37°C incubator and cultured upside down for 12 h, picked a single clone colony with a toothpick sterilized at 121°C, and used the universal primers T7: TAATACgACTCACTATAGG and T7-ter: GCTAGTTATTGCTCAGCGG of the pET-28a vector to identify positive clones by colony PCR. The PCR reaction was carried out according to the standard system in the instruction manual of the Phanta Max High-Fidelity DNA Polymerase Kit (P505-d1, Novozymes, China), and the reaction conditions were as follows:
[0060] Table 3 PCR amplification conditions for colony PCR identification
[0061] After colony PCR, positive clones were randomly picked and inoculated into liquid LB medium containing 50 μg / mL kanamycin, and cultured at 37°C for 12 h with shaking. The plasmids were extracted using a plasmid miniprep kit (Kangwei Century, China) and then Sanger sequencing was performed on the plasmids (Qingke, China) to confirm the correct clones. Example 2 Construction of HIS1 mutants and BL21 (DE3) recombinant strains
[0062] The HIS1 protein structure (PDB number: 8Y4U) in the protein data bank (PDB) was used as the input model and docked with mesotrione using Autodock 4 to obtain the binding model of HIS1 and the substrate. Based on the binding model, HIS1 single-point mutants G229A, G229M, F336A, F336D, F336N, F336E, F336Q, F336V, F336R, F336M, F336S, F336G, F336T, and F336C were designed, and the single-point mutants were combined to obtain double-point mutants G229M / F336R, G229M / F336C, G229A / F336D, G229A / F336N, G229A / F336E, G229A / F336Q, G229A / F336T, and F336C. V, G229A / F336R, G229A / F336M, G229A / F336S, G229A / F336G, G229A / F336T, G229A / F336C, G229A / F336A, G229M / F336D, G229M / F336N, G229M / F336E, G229M / F336Q, G229M / F336V, G229M / F336M, G229M / F336S, G229M / F336G, G229M / F336T, G229M / F336A. Upstream and downstream primers were designed based on the nucleic acid sequence encoding the mutant protein, and the whole plasmid PCR was performed using the pET-28a-HIS1 constructed in Example 1 as a template. The PCR reaction was performed according to the standard system in the instruction manual of the Phanta Max High-Fidelity DNA Polymerase Kit (P505-d1, Novozymes, China). The amplification conditions are shown in Table 4, and the upstream and downstream primers used in PCR are shown in Table 5:
[0063] Table 4 PCR amplification conditions of pET-28a-HIS1 plasmid vector
[0064]
[0065]
[0066]
[0067] Table 5 Primer sequences for HIS1 single point mutants
[0068] Primer Name Primer Sequence G229A-FW aggcctcactccgacGCAaccctcttgacgattcttctcgtcgaca G229M-FW aggcctcactccgacATGaccctcttgacgattcttctcgtcgaca G229-RW gtcggagtgaggcctgatgccg F336A-FW ttcagggccgggatcGCAggaaaattctctcgaggagagaggtacatcgactc F336D-FW ttcagggccgggatcGATggaaaattctctcgaggagagaggtacatcgactc F336N-FW ttcagggccgggatcAACggaaaattctctcgaggagagaggtacatcgactc F336E-FW ttcagggccgggatcGAAggaaaattctctcgaggagagaggtacatcgactc F336Q-FW ttcagggccgggatcCAAggaaaattctctcgaggagagaggtacatcgactc F336V-FW ttcagggccgggatcGTTggaaaattctctcgaggagagaggtacatcgactc F336R-FW ttcagggccgggatcCGGggaaaattctctcgaggagagaggtacatcgactc F336M-FW ttcagggccgggatcATGggaaaattctctcgaggagagaggtacatcgactc F336S-FW ttcagggccgggatcTCTggaaaattctctcgaggagagaggtacatcgactc F336G-FW ttcagggccgggatcGGAggaaaattctctcgaggagagaggtacatcgactc F336T-FW ttcagggccgggatcACCggaaaattctctcgaggagagaggtacatcgactc F336C-FW ttcagggccgggatcTGCggaaaattctctcgaggagagaggtacatcgactc F336-RW gatcccggccctgaactcttcgac
[0069] Among them, the upstream primer G229A-FW and the downstream primer G229-RW were used to amplify the vector amplification product containing the G229A mutation, the upstream primer G229M-FW and the downstream primer G229-RW were used to amplify the vector amplification product containing the G229M mutation, the upstream primer F336A-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the F336A mutation, and the upstream primer F336D-FW and the downstream primer F336D-FW were used to amplify the vector amplification product containing the F336A mutation. The upstream primer F336N-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the F336D mutation, the upstream primer F336N-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the F336N mutation, the upstream primer F336E-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the F336E mutation, the upstream primer F336Q-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the F336Q mutation. The upstream primer F336V-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the F336V mutation, the upstream primer F336R-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the F336R mutation, the upstream primer F336M-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the F336M mutation, the upstream primer F336S-FW and the downstream primer F336 -RW was used to amplify the vector amplification product containing the F336S mutation, the upstream primer F336G-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the F336G mutation, the upstream primer F336T-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the F336T mutation, and the upstream primer F336C-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the F336C mutation;
[0070] The restriction endonuclease Dpn I (TaKaRa, Japan) was used to digest the vector amplification products containing the mutation site obtained above to remove the methylated plasmid template. The reaction system and conditions were as follows: vector amplification products containing mutation sites, 20 μL; 10×T buffer, 4 μL; Dpn I (10U / μL), 1 μL; ddH2O, 15 μL; 37°C, 30 min. According to the instructions of the DNA purification kit (Axygen, USA), the amplified product HIS1 mutation fragment and pET-28a vector fragment were recovered. The purified fragments were connected together using C112 ligase (Novozyme, China). The reaction system and reaction conditions were as follows: 5× buffer, 2 μL; HIS1 mutation fragment, 1 μL; pET-28a vector fragment, 1 μL; C112 ligase, 1 μL; ddH2O, 5 μL; 37°C, 30 min.
[0071] Among them, the ligation products obtained according to the above method are pET-28a-G229A, pET-28a-G229M, pET-28a-F336A, pET-28a-F336D, pET-28a-F336N, pET-28a-F336E, pET-28a-F336Q, pET-28a-F336V, pET-28a-F336R, pET-28a-F336M, pET-28a-F336S, pET-28a-F336G, pET-28a-F336T and pET-28a-F336C respectively.
[0072] The above ligation products were transferred into 100 μL of slowly thawed BL21 (DE3) competent cells (Qingke, China), mixed by gentle pipetting, placed on ice for 30 min, in a 42°C water bath for 45 s, placed on ice for 2 min, added with 500 μL of liquid LB medium without antibiotics, and cultured at 37°C 220 rpm for 1 h. The plates were then spread on solid LB medium plates containing 50 μg / mL kanamycin, placed in an incubator at 37°C and cultured upside down for 12 h. Then, clones were randomly picked for Sanger sequencing verification (Qingke, China) to confirm the correct clones.
[0073] The correctly identified pET-28a-G229A was used as a template, and the upstream primers F336A-FW and the downstream primers F336-RW were used to amplify the vector amplification product containing the G229A / F336A double mutation. The upstream primers F336D-FW and the downstream primers F336-RW were used to amplify the vector amplification product containing the G229A / F336D double mutation. The upstream primers F336N-FW and the downstream primers F336-RW were used to amplify the vector amplification product containing the G229 The upstream primer F336E-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229A / F336E double mutation. The upstream primer F336Q-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229A / F336Q double mutation. The upstream primer F336V-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229A / F336 The upstream primer F336R-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229A / F336R double mutation, the upstream primer F336M-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229A / F336M double mutation, the upstream primer F336S-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229A / F336S double mutation. The upstream primer F336G-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229A / F336G double mutation, the upstream primer F336T-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229A / F336T double mutation, and the upstream primer F336C-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229A / F336C double mutation;
[0074] The correctly identified pET-28a-G229M was used as a template, and the upstream primer F336A-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229M / F336A double mutation. The upstream primer F336D-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229M / F336D double mutation. The upstream primer F336N-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229 The upstream primer F336E-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229M / F336E double mutation. The upstream primer F336Q-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229M / F336Q double mutation. The upstream primer F336V-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229M / F336 The upstream primer F336R-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229M / F336R double mutation, the upstream primer F336M-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229M / F336M double mutation, the upstream primer F336S-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229M / F336S double mutation. The upstream primer F336G-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229M / F336G double mutation, the upstream primer F336T-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229M / F336T double mutation, and the upstream primer F336C-FW and the downstream primer F336-RW were used to amplify the vector amplification product containing the G229M / F336C double mutation;
[0075] According to the above method, restriction endonuclease Dpn I (TaKaRa, Japan) digested the vector amplification products containing the double mutation sites obtained above and purified them to obtain the linearized pET-28a vector containing the HIS1 double mutation fragment, and the ligation and circularization were carried out by the above method to obtain the correctly identified ligation products as pET-28a-G229M / F336R, pET-28a-G229M / F336C, pET-28a-G229A / F336D, pET-28a-G229A / F336N, pET-28a-G229A / F336E, pET-28a-G229A / F336Q, pET-28a-G229A / F336V, pET-28a-G229M / F336R, pET-28a-G229M / F336C, pET-28a-G229A / F336D, pET-28a-G229A / F336N, pET-28a-G229A / F336E, pET-28a-G229A / F336Q, pET-28a-G229A / F336V. A / F336S, pET-28a-G229A / F336G, pET-28a-G229A / F336T, pET-28a-G229A / F336C and pET- 28a-G229A / F336A, pET-28a-G229M / F336D, pET-28a-G229M / F336N, pET-28a-G229M / F3 36E, pET-28a-G229M / F336Q, pET-28a-G229M / F336V, pET-28a-G229M / F336M, pET-28a- G229M / F336S, pET-28a-G229M / F336G, pET-28a-G229M / F336T, pET-28a-G229M / F336A. Finally, all correct clone mutants BL21(DE3)-pET-28a-G229A, BL21(DE3)-pET-28a-G229M, BL21(DE3)-pET-28a-F336A, BL21(DE3)-pET-28a-F336D, BL21(DE3)-pET-28a-F336N, BL21(DE3)-pET-28a-F336E, BL21(DE3)-pET-28 a-F336Q, BL21(DE3)-pET-28a-F336V, BL21(DE3)-pET-28a-F336R, BL21(DE3)-pET-28a-F336M, BL21(DE3 )-pET-28a-F336S, BL21(DE3)-pET-28a-F336G, BL21(DE3)-pET-28a-F336T and BL21(DE3)-pET-28a-F336C,BL21(DE3)-pET-28a-G229M / F336R, BL21(DE3)-pET-28a-G229M / F336C, BL21(DE3)-pET-28a-G229A / F336D, BL21 (DE3)-pET-28a-G229A / F336N, BL21(DE3)-pET-28a-G229A / F336E, BL21(DE3)-pET-28a-G229A / F336Q, BL21(DE3 )-pET-28a-G229A / F336V, BL21(DE3)-pET-28a-G229A / F336R, BL21(DE3)-pET-28a-G229A / F336M, BL21(DE3)-pE T-28a-G229A / F336S, BL21(DE3)-pET-28a-G229A / F336G, BL21(DE3)-pET-28a-G229A / F336T, BL21(DE3)-pET-28a -G229A / F336C, BL21(DE3)-pET-28a-G229A / F336A, BL21(DE3)-pET-28a-G229M / F336D, BL21(DE3)-pET-28a-G22 9M / F336N, BL21(DE3)-pET-28a-G229M / F336E, BL21(DE3)-pET-28a-G229M / F336Q, BL21(DE3)-pET-28a-G229M / F3 36V, BL21(DE3)-pET-28a-G229M / F336M, BL21(DE3)-pET-28a-G229M / F336S, BL21(DE3)-pET-28a-G229M / F336G, BL21(DE3)-pET-28a-G229M / F336T, BL21(DE3)-pET-28a-G229M / F336A were cultured in LB medium at 37°C overnight, and then an appropriate amount of glycerol was added and stored in a -80°C refrigerator for a long term.
[0076] Example 3: Expression and purification of target protein
[0077] 1) Expression of target protein
[0078] a. All the glycerol bacteria stored at -80°C obtained in Example 2 were streaked (the control was the wild-type cloned glycerol bacteria obtained in Example 1), cultured overnight on a 37°C medium plate, single clones were picked and added to 50 mL of LB medium containing Kan-resistant antibiotics, and cultured overnight at 37°C and 220 rpm;
[0079] b. Transfer the overnight bacteria in step a to a large bottle of 2xYT medium at an inoculum ratio of 1:100 and culture at 37°C and 220 rpm for 3 hours. 600 When the pH reaches 0.6-0.8, the temperature is lowered to 18°C, and then 0.1 mM IPTG is added for induction for 12-16 hours;
[0080] c. Centrifuge at 4°C, 7000 rpm for 8 min and collect the bacterial precipitate for protein purification.
[0081] 2) Purification of target protein (protein purification was performed at 4°C throughout the process)
[0082] a. fully resuspend all E. coli cells collected by centrifugation using a cell lysis solution, and then perform ultrasonic disruption;
[0083] b. After the ultrasound, centrifuge at 4°C and 12000 rpm for 30 min, and take the supernatant for affinity chromatography purification; during the purification process, use buffers containing 10mM and 250mM imidazole for elution respectively; after the elution is completed, analyze the results by SDS-PAGE;
[0084] c. According to the SDS-PAGE results, the target proteins were combined, desalted and concentrated to obtain purified G229A mutant protein, G229M mutant protein, F336A mutant protein, F336D mutant protein, F336N mutant protein, F336E mutant protein, F336Q mutant protein, F336V mutant protein, F336R mutant protein, F336M mutant protein, F336S mutant protein, F336G mutant protein, respectively. white, F336T mutant protein and F336C mutant protein, G229M / F336R double point mutant protein, G229M / F336C double point mutant protein, G229A / F336D double point mutant protein, G229A / F336N double point mutant protein, G229A / F336E double point mutant protein, G229A / F336Q double point mutant protein, G229A / F336V double point mutant protein, G229A / F336R Double point mutant protein, G229A / F336M double point mutant protein, G229A / F336S double point mutant protein, G229A / F336G double point mutant protein, G229A / F336T double point mutant protein, G229A / F336C double point mutant protein, G229A / F336A double point mutant protein, G229M / F336D double point mutant protein, G229M / F336N double point mutant protein, G229M / F 336E double point mutant protein, G229M / F336Q double point mutant protein, G229M / F336V double point mutant protein, G229M / F336M double point mutant protein, G229M / F336S double point mutant protein, G229M / F336G double point mutant protein, G229M / F336T double point mutant protein, G229M / F336A double point mutant protein and control wild-type HIS1 protein were used for subsequent enzyme activity determination.
[0085] Example 4: Determination of relative enzyme activity of target protein
[0086] Under the premise of ensuring that the concentrations of each protein and the active ingredient of the HPPD inhibitor herbicide are the same, the catalytic rate and degree of each protein on the HPPD inhibitor are tested by high performance liquid chromatography.
[0087] The specific test method steps are as follows:
[0088] a. Preparation of buffer solution, substrate and cofactors:
[0089] Activity test HEPES buffer: weigh 11.9 g HEPES powder to prepare 50 mL of 1 M stock solution, adjust the pH to 7.0 with 5 M sodium hydroxide, dilute to 50 mM before use, and filter with a 0.22 μm filter membrane;
[0090] Preparation of substrates: Weigh appropriate amounts of mesotrione and tembotrione respectively, prepare a 10 mM stock solution with DMSO, and dilute with activity assay buffer before use;
[0091] Preparation of sodium ascorbate: Dissolve 19.8 mg of sodium ascorbate in 1 mL of ultrapure water to a concentration of 100 mM and store at -80°C until use.
[0092] Preparation of ferrous sulfate: Dissolve 15.2 mg of ferrous sulfate in 1 mL of ultrapure water to a concentration of 100 mM and store at -80°C until use.
[0093] Preparation of α-ketoglutaric acid: Dissolve 14.6 mg of α-ketoglutaric acid in 1 mL of ultrapure water to a concentration of 100 mM and store at -80°C until use.
[0094] b. When measuring activity, first mix the activity measuring HEPES buffer (final concentration of 20mM) with the substrate (0.5mM mesotrione and 0.5mM cyproconazole), α-ketoglutaric acid (final concentration of 2.5mM), sodium ascorbate (final concentration of 1mM) and ferrous sulfate (final concentration of 1mM), and finally add an appropriate amount of the enzyme solution obtained in Example 3 (final concentration of 0.5mg / mL), react at 28°C for 10h, and the total reaction volume is 100μL. After the reaction is completed, methanol is used to terminate the reaction, and the catalytic efficiency is detected by high performance liquid chromatography (HPLC), and the catalytic activity of the wild-type HIS1 protein is used as a benchmark to characterize the relative enzyme activity of the mutant. Each set of data is measured 3 times, and then the average value is taken. Among them:
[0095] Control: The active HEPES buffer (final concentration of 20 mM) was mixed with substrates (mesotrione and tampoxone with a final concentration of 0.5 mM, respectively), α-ketoglutaric acid (final concentration of 2.5 mM), sodium ascorbate (final concentration of 1 mM) and ferrous sulfate (final concentration of 1 mM), and finally the inactivated enzyme solution was added, and the reaction was carried out at 28°C for 10 hours, and the total reaction volume was 100 μL. After the reaction was completed, methanol was used to terminate the reaction, and the amount of substrate was detected by high performance liquid chromatography (HPLC), and it was used as the total amount of substrate when no reaction occurred.
[0096] Sample: The active HEPES buffer (final concentration of 20 mM) was mixed with substrates (mesotrione and tembotrione with a final concentration of 0.5 mM, respectively), α-ketoglutaric acid (final concentration of 2.5 mM), sodium ascorbate (final concentration of 1 mM) and ferrous sulfate (final concentration of 1 mM), and finally an appropriate amount of the enzyme solution prepared in Example 3 (final concentration of 0.5 mg / mL) was added, and the reaction was carried out at 28° C. for 10 h, and the total reaction volume was 100 μL. After the reaction was completed, methanol was used to terminate the reaction, and the amount of substrate was detected by high performance liquid chromatography (HPLC), and the reaction efficiency was calculated by comparison with the control phase.
[0097] In this example, the catalytic efficiency of the wild-type HIS1 protein and its mutants on two representative HPPD inhibitor herbicides (mesotrione and tembotrione) was tested. The specific results are shown in Figures 2 - 5 .from Figure 2 and Figure 3 It can be seen that several HIS1 mutants such as G229A, G229M, F336A, F336D, F336N, F336E, F336Q, F336V, F336R, F336M, F336S, F336G, F336T and F336C have significantly improved activities against mesotrione and tembotrione compared with wild-type HIS1, and can be used to construct double-point mutants. Figure 4 and Figure 5 It can be seen that the mutants G229M / F336R and G229M / F336C have a certain improvement in the catalytic activity of mesotrione compared with the wild type, but have a certain decrease in the catalytic activity of tembotrione; while G229A / F336D, G229A / F336N, G229A / F336E, G229A / F336Q, G229A / F336V, G229A / F336R, G229A / F336M, G229A / F336S, G229A / F336G, G229A / F336T, G229A / F336 Compared with the wild-type HIS1, several HIS1 mutants, including 6C, G229A / F336A, G229M / F336D, G229M / F336N, G229M / F336E, G229M / F336Q, G229M / F336V, G229M / F336M, G229M / F336S, G229M / F336G, G229M / F336T, and G229M / F336A, showed significantly improved activities towards mesotrione and cyproconazole. Among them, G229A / F336N had the best catalytic effect and was the optimal mutant.
[0098] Example 5: Agrobacterium-mediated genetic transformation of rice and resistance identification of transgenic positive plants
[0099] 1) Construction of rice expression vectors for wild-type and mutant HIS1 genes and Agrobacterium transformation
[0100] According to the coding region sequence of rice HIS1 gene, gene-specific primers with restriction sites and protective bases added at both ends were designed, HIS1-1: CGGGGTACCatggctgacgagtcatggag and HIS1-2: CGCGGATCCgatcctcagggagtcgatgtacc, and the pET28a vector of wild-type HIS1 gene obtained in Example 1 and all pET28a vectors containing mutant HIS1 gene obtained in Example 2 were used as templates to amplify DNA sequences containing the coding region of the corresponding wild-type and / or mutant HIS1 gene. The corresponding expression vector (with pCAMBIA1390 vector as the backbone, Hyg as the screening marker gene, and the expression cassette of ZmUbi promoter-NOS terminator driven expression of the target gene, the complete sequence of the vector is shown in SEQ ID No. 3) was constructed by homologous recombination (ClonExpress II One Step Cloning Kit, Norwegian). The NIT software was used to compare the wild-type HIS1 gene sequence of rice to verify the correctness of the corresponding open reading frame and the promoter linker. The constructed plasmid vectors were transformed into Agrobacterium EHA105, and the bacteria were cultured. The conventional Agrobacterium-mediated method was used to transform the japonica rice Nipponbare, and the operation process was referred to the method described in the literature (Agrobacterium-mediated transformation of rice using immature embryos or calliinduced from mature seed [J]. Nat Protoc, 2008; 3 (5): 824-34.).
[0101] The transgenic rice seedlings obtained in the above steps were transplanted into soil and planted in a 32°C greenhouse under long-day conditions. When the transgenic plants grew to the 4-5 leaf stage, the DNA of the surviving transgenic seedlings was extracted using a kit (Cambia, China) as a template, and PCR amplification was performed using primers PUBI-SF: GCCCTGCCTTTCATACGCT and pCambia1390-RW: GAAATTCGAGCTGGTCACCTGTAATTCA to screen out HIS1 transgenic positive plants.
[0102] 2) Resistance identification of transgenic positive plants
[0103] According to the T0 generation tissue culture seedlings that successfully overexpressed wild-type HIS1 and mutant HIS1-G229A / F336N, the T0 generation plants were transplanted into an artificial climate chamber and harvested in bags; the T1 generation plants of the offspring group were sown and the overexpression positive plants were identified; the stems and leaves of the 3-5 leaf stage HIS1-G229A / F336N mutant T1 generation positive rice plants and the HIS1 wild-type T1 generation positive rice plants were sprayed with 180 g ai / ha of mesotrione and 45 g ai / ha of cypermethrin aqueous solution, and the HIS1 wild-type T1 generation positive rice plants were used as controls to test the resistance of the HIS1-G229A / F336N mutant to mesotrione and cypermethrin. The specific results are shown in Figure 6 As can be seen from the figure, under the conditions of mesotrione spraying dosage of 180 g ai. / ha and cyproconazole spraying dosage of 45 g ai. / ha, almost all the T1 generation positive rice plants of the HIS1 wild type showed albinism symptoms, while the T1 generation positive rice plants of the HIS1-G229A / F336N mutant basically maintained the normal green color, indicating that the HIS1-G229A / F336N mutant can indeed improve the resistance of rice plants to the triketone HPPD inhibitor herbicides mesotrione and cyproconazole.
[0104] Example 6: Agrobacterium-mediated genetic transformation of wheat and resistance identification of transgenic positive plants
[0105] 1) Construction of wheat expression vectors for wild-type and mutant TaHIS1 genes and Agrobacterium transformation
[0106] According to the coding region sequence of wheat HIS1 (TaHIS1) gene (SEQ ID No. 4), gene-specific primers with restriction sites added at both ends (F: 5'-GGTACCatggctgcgtccgacg-3' and R: 5'-GGATCCtatcttcagggtgtcgatgaatctcttcc-3') were designed. The cDNA of Ningmai 36 (Analysis of Yield and Quality Traits of New Weak-Gluten Wheat Cultivar'Ningmai 36'. Chinese Agricultural Science Bulletin. 2024, 40(9): 20-24 https: / / doi.org / 10.11924 / j.issn.1000-6850.casb2023-0356) was used as a template to amplify the gene sequence encoding TaHIS1 protein in wheat. The TaHIS1 protein was expressed in 40% succinate and expressed in 1% succinate by homologous recombination (ClonExpress II One Step Cloning The corresponding plant expression vector (with pCAMBIA1390 vector as the backbone, Bar as the screening marker gene, and the expression frame of ZmUbi promoter-NOS terminator to drive the expression of the target gene) was constructed using Vector NIT software, and the sequence of the wild-type wheat TaHIS1 gene was compared to verify the correctness of the corresponding open reading frame and the promoter linker.
[0107] The method for constructing a plant expression vector of a wheat HIS1 mutant is as follows: first, using the cDNA of Ningmai 36 as a template, using primers Ta-FW: GAAGGAGATATACATatggctgcgtccgacgag and Ta-RW: GTGGTGGTGCTCGAGtatcttcagggtgtcgatgaatctcttccc to amplify the gene sequence encoding the TaHIS1 protein in wheat, the PCR amplification system and conditions are the same as those in Example 1, and then constructing a pET-28a-TaHIS1 vector according to the method described in Example 1; using the pET-28a-TaHIS1 vector as a template, using primers G230A-FW: aggcctcactctgatGCC aatctccttactatcctttttgtcgacgac and primer G230-RW: atcagagtgaggcctgaggc were used for whole plasmid PCR, and then the vector pET-28a-TaHIS1-G230A was constructed according to the method described in Example 2; pET-28a-TaHIS1-G230A vector was used as a template, and whole plasmid PCR was performed using primers F337N-FW: ttcgtggctgggctcAACgaacatttccgtcaagggaagagattcatcgacaccctg and primer F337-RW: gagcccagccacgaaatccttggtcagcattttc. Referring to the amino acid sequence of the rice HIS1-G229A / F336N mutant, the corresponding sites in the wheat expression vector were mutated to construct the plant expression vector of TaHIS1-G230A / F337N. Specifically, the vector pET-28a-TaHIS1-G230A / F337N was constructed according to the method described in Example 2; pET-28a-TaHIS1-G230A / F337N was used as a template, and the gene sequence encoding the TaHIS1 mutant protein G230A / F337N was amplified using primers (F: 5'-GGTACCatggctgcgtccgacg-3' and R: 5'-GGATCCtatcttcagggtgtcgatgaatctcttcc-3'), and the corresponding plant expression vector (with pCAMBIA1390 vector as the backbone, Bar as the screening marker gene, and the expression frame of the ZmUbi promoter-NOS terminator driven to express the target gene) was constructed by homologous recombination (ClonExpress II One Step Cloning Kit, Norwegian), and the vector was compared with the wild-type wheat TaHIS1 gene sequence using Vector NIT software to verify the correctness of the corresponding open reading frame and the promoter linker.
[0108] The constructed plasmid vector was transformed into Agrobacterium EHA105 and the bacteria were cultured. The conventional Agrobacterium-mediated method was used to transform Ningmai 36 wheat varieties. The transformation operation process was carried out according to the method described in the reference (An efficient and reproducible Agrobacterium-mediated transformation method for hexaploid wheat (Triticum estivum L.) [J]. Plant Methods, 2019; 15 (121)).
[0109] The wheat transgenic seedlings obtained in the above steps were transplanted into the soil and planted in a 32°C greenhouse under long-day conditions. When the transgenic plants grew to the 4-5 leaf stage, the DNA of the surviving transgenic seedlings was extracted using a kit (Kangwei Century, China) as a template, and PCR amplification was performed using primers PUBI-SF and pCambia1390-RW. The individual plant that could amplify the target band was the TaHIS1 transgenic positive plant.
[0110] 2) Resistance identification of transgenic positive plants
[0111] T0 generation tissue culture seedlings that successfully overexpressed wild-type TaHIS1 and mutant TaHIS1-G230A / F337N were screened, and T0 generation plants were transplanted into an artificial climate chamber and harvested in bags; T1 generation plants of the offspring group were sown, and overexpression positive plants were identified; TaHIS1-G230A / F337N mutant T1 generation positive wheat plants and TaHIS1 wild-type T1 generation positive wheat plants at the 4-5 leaf stage were sprayed with 420 g ai. / ha of mesotrione and 360 g ai / ha of cyproconazole aqueous solution on the stems and leaves, and TaHIS1 wild-type T1 generation positive wheat plants were used as controls to test the resistance of TaHIS1-G230A / F337N mutants to mesotrione and cyproconazole. The specific results are shown in Figure 7 As can be seen from the figure, under the conditions of mesotrione spraying dosage of 420g ai / ha and cyproconazole spraying dosage of 360g ai / ha, TaHIS1 wild-type T1 generation positive wheat plants almost all showed albinism symptoms, while TaHIS1-G230A / F337N mutant T1 generation positive wheat plants basically maintained normal green color, indicating that TaHIS1-G230A / F337N mutant can indeed improve the resistance of wheat plants to triketone HPPD inhibitor herbicides mesotrione and cyproconazole.
Claims
1. A HIS1 mutant protein, characterized in that The HIS1 mutant protein is selected from at least one of the following proteins (a), (b), (c) or (d): (a) A wild-type rice HIS1 protein has a mutation at the 229th amino acid position or a homologous HIS1 protein of other plants at the corresponding position, so that the protein has α-ketoglutarate-dependent oxygenase activity and / or mesotrione resistance and / or tembotrione resistance; the amino acid sequence of the wild-type rice HIS1 protein is shown in SEQ ID No. 1; (b) A wild-type rice HIS1 protein has a mutation at amino acid position 336 or a homologous HIS1 protein of other plants at a corresponding position, so that the wild-type rice HIS1 protein has α-ketoglutarate-dependent oxygenase activity and / or mesotrione resistance and / or tembotrione resistance; the amino acid sequence of the wild-type rice HIS1 protein is shown in SEQ ID No. 1; (c) a protein derived from (a) wherein the amino acid sequence in (a) or (b) is substituted, deleted or added with one or more amino acids and has α-ketoglutarate-dependent oxygenase activity and / or mesotrione resistance and / or tembotrione resistance; (d) a protein having at least 85% amino acid sequence identity with any of the HIS1 mutant proteins in (a), (b) or (c) above, and having higher α-ketoglutarate-dependent oxygenase activity and / or mesotrione resistance and / or tembotrione resistance than the plant wild-type HIS1 protein.
2. The HIS1 mutant protein according to claim 1, characterized in that The HIS1 mutant protein is selected from at least one of the following proteins (1), (2) or (3): (1) A protein derived from the amino acid 229 of the amino acid sequence shown in SEQ ID NO.1 or a HIS1 homologous protein of other plants mutated from glycine to alanine or methionine at the corresponding position; (2) A protein derived from the amino acid 336 in the amino acid sequence of SEQ ID NO.1 or a HIS1 homologous protein of other plants mutated from phenylalanine to alanine, aspartic acid, asparagine, glutamic acid, glutamine, valine, arginine, methionine, serine, glycine, threonine or cysteine at the corresponding position; (3) A protein derived from a mutation simultaneously occurring at amino acid position 229 and amino acid position 336 in the amino acid sequence of SEQ ID NO. 1 or at the corresponding positions of other plant HIS1 homologous proteins, specifically selected from the following mutation forms: G229A / F336D, G229A / F336N, G229A / F336E, G229A / F336Q, G229A / F336V, G229A / F336R, G229A / F336M, G229A / F336S, G229A / F336 6G, G229A / F336T, G229A / F336C, G229A / F336A, G229M / F336D, G229M / F336N, G229M / F336E, G229M / F336Q, G229 M / F336V, G229M / F336R, G229M / F336M, G229M / F336S, G229M / F336G, G229M / F336T, G229M / F336C or G229M / F336A.
3. The HIS1 mutant protein according to claim 1 or 2, characterized in that The other plants include wheat, corn, soybean, cotton or rapeseed; when the plant is wheat, the site corresponding to the 229th amino acid site of the wild-type rice HIS1 protein is located at the 230th amino acid of the wild-type wheat HIS1 homologous protein; the site corresponding to the 336th amino acid site of the wild-type rice HIS1 protein is located at the 337th amino acid of the wild-type wheat HIS1 homologous protein.
4. The HIS1 mutant protein according to claim 3, characterized in that When the plant is wheat, the wheat HIS1 mutant protein is selected from at least one of the following proteins (i), (ii) or (iii): (i) a protein derived from the amino acid sequence of SEQ ID NO.5 wherein the 230th amino acid is mutated from glycine to alanine or methionine; (ii) a protein derived from the amino acid sequence of SEQ ID NO. 5 wherein the amino acid at position 337 is mutated from phenylalanine to alanine, aspartic acid, asparagine, glutamic acid, glutamine, valine, arginine, methionine, serine, glycine, threonine or cysteine; (iii) a protein derived from a simultaneous mutation of amino acid 230 and amino acid 337 in the amino acid sequence of SEQ ID NO.5, specifically selected from the following mutant forms: G230A / F337D, G230A / F337N, G230A / F337E, G230A / F337Q, G230A / F337V, G230A / F337R, G230A / F337M, G230A / F337S, G230A / F337G, G230A / F337V 37T, G230A / F337C, G230A / F337A, G230M / F337D, G230M / F337N, G230M / F336E, G230M / F337Q, G230M / F337 V, G230M / F337R, G230M / F337M, G230M / F337S, G230M / F337G, G230M / F337T, G230M / F337C or G230M / F337A.
5. A HIS1 A mutant gene, characterized in that It encodes the HIS1 mutant protein according to any one of claims 1 to 4.
6. According to claim 5 HIS1 A mutant gene, characterized in that The mutant gene includes any of the following gene sequences: (1) The mutant gene is different from the wild type of rice HIS1 The nucleotides at positions 685 to 687 of the gene are mutated to gca, gct, gcc, gcg or atg, and the wild type rice HIS1 The nucleotide sequence of the gene is shown in SEQ ID NO.2; (2) The mutant gene is different from the wild type of rice HIS1 The nucleotides at positions 1006 to 1008 of the gene are mutated to att, aac, gaa, gag, gat, gac, caa, cag, gtt, gtc, gta, gtg, cgt, cgc, cga, cgg, aga, agg, atg, tct, tcc, tca, tcg, agt, agc, ggt, ggc, gga, ggg, act, acc, aca, acg, tgt, tgc, gca, gct, gcc or gcg, and the rice wild type HIS1 The nucleotide sequence of the gene is shown in SEQ ID NO.2; (3) The mutant gene is different from the wild type of wheat HIS1 The nucleotides at positions 688 to 690 of the gene are mutated to gca, gct, gcc, gcg or atg, and the wild type wheat HIS1 The nucleotide sequence of the gene is shown in SEQ ID NO.4; (4) The mutant gene is different from the wild type of wheat HIS1 The nucleotides at positions 1009 to 1011 of the gene are mutated to att, aac, gaa, gag, gat, gac, caa, cag, gtt, gtc, gta, gtg, cgt, cgc, cga, cgg, aga, agg, atg, tct, tcc, tca, tcg, agt, agc, ggt, ggc, gga, ggg, act, acc, aca, acg, tgt, tgc, gca, gct, gcc or gcg, and the wheat wild type HIS1 The nucleotide sequence of the gene is shown in SEQ ID NO.
4.
7. An expression cassette, a recombinant vector or a recombinant bacterium containing the HIS1 Mutant gene.
8. The HIS1 mutant protein according to any one of claims 1 to 4, or the HIS1 mutant protein according to claim 5 or 6 HIS1 The use of the mutant gene, the expression cassette, the recombinant vector or the recombinant bacterium according to claim 7 in cultivating plants resistant to HPPD inhibitor herbicides, wherein the HPPD inhibitor herbicides preferably include one or both of mesotrione or cyproconazole.
9. A method for obtaining plants resistant to HPPD inhibitor herbicides, comprising the steps of: (1) causing a plant to contain the mutant gene according to claim 5 or 6; or (2) causing a plant to express the protein according to any one of claims 1 to 4.
10. A method for identifying plants resistant to HPPD inhibitor herbicides comprising the steps of: (1) testing whether a plant contains the mutant gene according to claim 5 or 6; or (2) Testing whether a plant expresses the protein according to any one of claims 1 to 4.
Citation Information
Patent Citations
Mutated HIS1 polypeptide and application thereof
CN117568293A
HSL protein, gene, vector, cell, composition, application and method for improving herbicide resistance of crops
CN117586973A
Triketone dioxygenase variants for herbicide tolerance
CN118591285A
